Non-exposed endoscopic wall-inversion surgery with one-step nucleic acid amplification for early gastrointestinal tumors: Personal experience and literature review
- PMID: 37426319
- PMCID: PMC10324533
- DOI: 10.3748/wjg.v29.i24.3883
Non-exposed endoscopic wall-inversion surgery with one-step nucleic acid amplification for early gastrointestinal tumors: Personal experience and literature review
Abstract
Background: Laparoscopic and endoscopic cooperative surgery is a safe, organ-sparing surgery that achieves full-thickness resection with adequate margins. Recent studies have demonstrated the safety and efficacy of these procedures. However, these techniques are limited by the exposure of the tumor and mucosa to the peritoneal cavity, which could lead to viable cancer cell seeding and the spillage of gastric juice or enteric liquids into the peritoneal cavity. Non-exposed endoscopic wall-inversion surgery (NEWS) is highly accurate in determining the resection margins to prevent intraperitoneal contamination because the tumor is inverted into the visceral lumen instead of the peritoneal cavity. Accurate intraoperative assessment of the nodal status could allow stratification of the extent of resection. One-step nucleic acid amplification (OSNA) can provide a rapid method of evaluating nodal tissue, whilst near-infrared laparoscopy together with indocyanine green can identify relevant nodal tissue intraoperatively.
Aim: To determine the safety and feasibility of NEWS in early gastric and colon cancers and of adding rapid intraoperative lymph node (LN) assessment with OSNA.
Methods: The patient-based experiential portion of our investigations was conducted at the General and Oncological Surgery Unit of the St. Giuseppe Moscati Hospital (Avellino, Italy). Patients with early-stage gastric or colon cancer (diagnosed via endoscopy, endoscopic ultrasound, and computed tomography) were included. All lesions were treated by NEWS procedure with intraoperative OSNA assay between January 2022 and October 2022. LNs were examined intraoperatively with OSNA and postoperatively with conventional histology. We analyzed patient demographics, lesion features, histopathological diagnoses, R0 resection (negative margins) status, adverse events, and follow-up results. Data were collected prospectively and analyzed retrospectively.
Results: A total of 10 patients (5 males and 5 females) with an average age of 70.4 ± 4.5 years (range: 62-78 years) were enrolled in this study. Five patients were diagnosed with gastric cancer. The remaining 5 patients were diagnosed with early-stage colon cancer. The mean tumor diameter was 23.8 ± 11.6 mm (range: 15-36 mm). The NEWS procedure was successful in all cases. The mean procedure time was 111.5 ± 10.7 min (range: 80-145 min). The OSNA assay revealed no LN metastases in any patients. Histologically complete resection (R0) was achieved in 9 patients (90.0%). There was no recurrence during the follow-up period.
Conclusion: NEWS combined with sentinel LN biopsy and OSNA assay is an effective and safe technique for the removal of selected early gastric and colon cancers in which it is not possible to adopt conventional endoscopic resection techniques. This procedure allows clinicians to acquire additional information on the LN status intraoperatively.
Keywords: Early colorectal cancer; Early gastric cancer; Endoscopic full-thickness resection; Laparoscopic and endoscopic cooperative surgery; Non-exposed endoscopic wall inversion surgery; One-step nucleic acid amplification; Sentinel lymph node.
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Figures






Similar articles
-
Intraoperative identification and analysis of lymph nodes at laparoscopic colorectal cancer surgery using fluorescence imaging combined with rapid OSNA pathological assessment.Surg Endosc. 2018 Feb;32(2):1073-1076. doi: 10.1007/s00464-017-5644-4. Epub 2017 Jun 22. Surg Endosc. 2018. PMID: 28643063 Free PMC article. Clinical Trial.
-
Prospective feasibility study for single-tracer sentinel node mapping by ICG (indocyanine green) fluorescence and OSNA (one-step nucleic acid amplification) assay in laparoscopic gastric cancer surgery.Gastric Cancer. 2019 Jul;22(4):873-880. doi: 10.1007/s10120-018-00919-3. Epub 2019 Jan 3. Gastric Cancer. 2019. PMID: 30603913
-
One-step nucleic acid amplification (OSNA) for the application of sentinel node concept in gastric cancer.Ann Surg Oncol. 2011 Aug;18(8):2289-96. doi: 10.1245/s10434-011-1591-9. Epub 2011 Feb 8. Ann Surg Oncol. 2011. PMID: 21301968
-
One-step nucleic acid amplification (OSNA): where do we go with it?Int J Clin Oncol. 2017 Feb;22(1):3-10. doi: 10.1007/s10147-016-1030-9. Epub 2016 Aug 22. Int J Clin Oncol. 2017. PMID: 27549784 Review.
-
Minimally Invasive Function-Preserving Gastrectomy with Sentinel Node Biopsy for Early Gastric Cancer.Digestion. 2019;99(1):14-20. doi: 10.1159/000494407. Epub 2018 Dec 14. Digestion. 2019. PMID: 30554230 Review.
Cited by
-
Nonexposed endoscopic wall inversion surgery with sentinel node mapping for a high risk gastric lesion.Endoscopy. 2024 Dec;56(S 01):E527. doi: 10.1055/a-2342-0221. Epub 2024 Jun 18. Endoscopy. 2024. PMID: 38889895 Free PMC article. No abstract available.
References
-
- Nishida T, Hirota S, Yanagisawa A, Sugino Y, Minami M, Yamamura Y, Otani Y, Shimada Y, Takahashi F, Kubota T GIST Guideline Subcommittee. Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version. Int J Clin Oncol. 2008;13:416–430. - PubMed
-
- Iwahashi M, Takifuji K, Ojima T, Nakamura M, Nakamori M, Nakatani Y, Ueda K, Ishida K, Naka T, Ono K, Yamaue H. Surgical management of small gastrointestinal stromal tumors of the stomach. World J Surg. 2006;30:28–35. - PubMed
-
- Onimaru M, Inoue H, Ikeda H, Abad MRA, Quarta Colosso BM, Shimamura Y, Sumi K, Deguchi Y, Ito H, Yokoyama N. Combination of laparoscopic and endoscopic approaches for neoplasia with non-exposure technique (CLEAN-NET) for gastric submucosal tumors: updated advantages and limitations. Ann Transl Med. 2019;7:582. - PMC - PubMed
-
- The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003;58:S3–43. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources